IL157303A0 - Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone - Google Patents

Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone

Info

Publication number
IL157303A0
IL157303A0 IL15730302A IL15730302A IL157303A0 IL 157303 A0 IL157303 A0 IL 157303A0 IL 15730302 A IL15730302 A IL 15730302A IL 15730302 A IL15730302 A IL 15730302A IL 157303 A0 IL157303 A0 IL 157303A0
Authority
IL
Israel
Prior art keywords
gonadotropin
isoquinoline
quinoline
antagonists
releasing hormone
Prior art date
Application number
IL15730302A
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2001108271 external-priority patent/DE10108271A1/en
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of IL157303A0 publication Critical patent/IL157303A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30—Phthalazines
    • C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
IL15730302A 2001-02-21 2002-02-21 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone IL157303A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2001108271 DE10108271A1 (en) 2001-02-21 2001-02-21 New oxo substituted quinoline, isoquinoline and phthalazine derivatives useful as GnRH antagonists in male fertility control, female infertility and contraception and tumor control
US27491401P 2001-03-13 2001-03-13
PCT/EP2002/001882 WO2002066437A1 (en) 2001-02-21 2002-02-21 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone

Publications (1)

Publication Number Publication Date
IL157303A0 true IL157303A0 (en) 2004-02-19

Family

ID=26008581

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15730302A IL157303A0 (en) 2001-02-21 2002-02-21 Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone

Country Status (17)

Country Link
EP (1) EP1362034A1 (en)
JP (1) JP2004528298A (en)
CN (1) CN1496354A (en)
AU (1) AU2002247737B2 (en)
BG (1) BG108165A (en)
BR (1) BR0207451A (en)
CA (1) CA2438709A1 (en)
CZ (1) CZ20032514A3 (en)
HU (1) HUP0303219A2 (en)
IL (1) IL157303A0 (en)
MX (1) MXPA03007348A (en)
NO (1) NO325675B1 (en)
NZ (1) NZ527597A (en)
PL (1) PL367285A1 (en)
RU (1) RU2280031C2 (en)
SK (1) SK11622003A3 (en)
WO (1) WO2002066437A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9783529B2 (en) * 2013-03-13 2017-10-10 Flatley Discovery Lab, Llc Pyridazinone compounds and methods for the treatment of cystic fibrosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69623655T2 (en) * 1995-10-19 2003-04-24 Takeda Chemical Industries, Ltd. CHINOLINE DERIVATIVES AS GNRH ANTAGONISTS
AU712019B2 (en) * 1996-05-20 1999-10-28 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone

Also Published As

Publication number Publication date
SK11622003A3 (en) 2004-01-08
NZ527597A (en) 2004-10-29
CZ20032514A3 (en) 2004-05-12
BR0207451A (en) 2004-06-01
CA2438709A1 (en) 2002-08-29
NO325675B1 (en) 2008-07-07
AU2002247737B2 (en) 2006-05-18
JP2004528298A (en) 2004-09-16
CN1496354A (en) 2004-05-12
HUP0303219A2 (en) 2003-12-29
BG108165A (en) 2004-08-31
PL367285A1 (en) 2005-02-21
EP1362034A1 (en) 2003-11-19
RU2003128647A (en) 2005-03-27
NO20033698L (en) 2003-10-20
RU2280031C2 (en) 2006-07-20
NO20033698D0 (en) 2003-08-20
WO2002066437A1 (en) 2002-08-29
MXPA03007348A (en) 2003-12-04

Similar Documents

Publication Publication Date Title
MXPA03001928A (en) Quinoline and quinazoline derivatives.
HUP0100941A3 (en) Quinoline, quinazoline and pyrido-pyrimidine derivatives and pharmaceutical compositions thereof
HK1049839A1 (en) Quinoline and quinazoline derivatives and drugs containing the same
HUP0105133A3 (en) Quinoline derivatives and quinazoline derivatives, pharmaceutical compositions containing them and their use
HK1081193A1 (en) Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents
HK1074176A1 (en) Quinoline derivatives as neuropeptide y antagonists
HK1082249A1 (en) Isoquinoline derivatives having kinasae inhibitoryactivity and drugs containing the same
IL165986A0 (en) Isoquinoline and quinazoline derivatives and pharmaceutical compositions containing the same
MXPA02008402A (en) Derivatives of quinoline as alpha-2 antagonists.
HK1078266A1 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
GB9904103D0 (en) Quinoline derivatives
IL161597A0 (en) Therapeutic quinoline compounds with 5-ht-antagonistic properties
AU7653601A (en) Quinoline derivatives having vegf inhibiting activity
AU2002321878A1 (en) Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
HUP0100832A3 (en) Quinoxaline and quinoline carboxamide derivatives, their use and the pharmaceutical compositions containing them
ZA200201521B (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparation containing the same, and methods of using the same.
AU2002215043A1 (en) Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
HUP0203611A3 (en) 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments
HUP0401986A3 (en) Injection solution comprising an lhrh antagonist and process for its preparation
AU2002220702A1 (en) Quinoline derivatives as nk-3 and nk-2 antagonists
AU2003224482A8 (en) Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
IL157303A0 (en) Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
AU2002302735A1 (en) 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists
AU2002247737A1 (en) Quinoline, isoquinoline and phthalazine derivatives as antagonists of the gonadotropin-releasing hormone
AU2003210062A1 (en) Agonists and antagonists of gonadotropin-releasing hormone-2, and use thereof